Enveric Biosciences Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on July 15, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split … [Read more…]